ApexOnco and other media outlets reported that the FDA has placed a partial clinical hold on the phase III IDeate-Lung02 trial after more patients died from interstitial lung disease than anticipated; ...
Main Finding: A phase I/II trial supported the safety and efficacy of intermittent administration of VT3989 for the treatment of mesothelioma. Concept: Blocking TEAD autopalmitoylation effectively ...
A recent study of more than 20,000 girls ages 12 to 16 found that, when it comes to preventing cervical cancer, one dose of the human papillomavirus (HPV) vaccine is as effective as two, which is the ...
1Division of Hematology, Brigham and Women’s Hospital, Boston, Massachusetts. 2Department of Medicine, Harvard Medical School, Boston, Massachusetts. 3Broad Institute of MIT and Harvard, Cambridge, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback